News

After previously going bankrupt, center is now under US ownership for the first time

Supply deal with Takeda to begin distribution in early 2022, pending shot approval

Drug maker to supply European Union with 60 million doses by end of Q3

Objective is to provide efficiency for analytics company’s medical information department

Swiss organization will take patient-centric approach towards developing injectables

Company’s prospective malaria and tuberculosis doses will be developed in Rwanda, Senegal

Irvine, CA, location will house 40,000 square feet of oral solid dosage forms

Agreement will focus on developing, manufacturing and commercializing biosimilars in the respiratory space

Meeting future expectations in pharmaceutical sustainability a key component of shipping collaboration

Healthcare tech company acquires Medical Marketing Economics, a provider of value-based strategy support

The latest people news happenings over the past month

Gene therapy tech collaboration will target treatment development for Alzheimer's, Parkinson's and rare diseases

Wholesaler's 3PL arm to provide logistics and distribution support to potential emergency use drug for patients with critical Covid with respiratory failure

Program expands an ongoing effort at Wake Forest

Swiss CDMO’s expansion at recently opened Guangzhou plant expected to be ready by next year

CAGR growth through 2026 will be 6.4% per year

Deal for CHC Health adds depth, scale and expanded clinical expertise in health outcomes pursuits

Venture anticipated to more than double single-use bioreactor mammalian cell-culture capacity on site

Agency hopes Pfizer-BioNTech jab approval will convince some in public to get vaccinated

CDMO's expansion of Rensselaer, NY, facility will help grow its API division

Acquisition addresses the need for meeting healthcare sector’s patient support demand

Cardiff center will help produce lipids that are necessary for mRNA Covid vaccines

Developments include the creation of a new microbial facility, expansion of mammalian center

Deal allows for bicoastal expansion of pharmaceutical services

Plan aims to offset costs associated with proposed social and health initiatives

Company is also cited by SAP; meanwhile, HDA attendees get cautioned by FDA

Announcement only applies to mRNA doses at this point

End result is an enhanced method for developing vaccinia capping enzyme (VCE), parties say